NBIX vs AAPL: Which Stock is Better?
Side-by-side comparison of Neurocrine Biosciences Inc and Apple Inc in 2026
NBIX
Neurocrine Biosciences Inc
$153.88
AAPL
Apple Inc
$315.98
Key Metrics Comparison
| Metric | NBIX | AAPL | Winner |
|---|---|---|---|
| Market Cap | $13.21B | $3.83T | AAPL |
| P/E Ratio | 31.57 | 34.84 | NBIX |
| EPS (TTM) | $4.19 | $7.47 | AAPL |
| Revenue Growth | 27.8% | 7.9% | NBIX |
| Gross Margin | 0.0% | 46.9% | AAPL |
Analyze NBIX
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is NBIX or AAPL a better investment?
Comparing NBIX and AAPL: Neurocrine Biosciences Inc has a market cap of $13.21B while Apple Inc has $3.83T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between NBIX and AAPL?
NBIX (Neurocrine Biosciences Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: NBIX or AAPL?
Based on P/E ratios, NBIX trades at a lower multiple (31.6x vs 34.8x).
Which is growing faster: NBIX or AAPL?
NBIX has higher revenue growth at 27.8% vs 7.9% for AAPL.
Which company is more profitable: NBIX or AAPL?
Apple Inc (AAPL) has higher gross margins at 46.9% compared to 0.0% for NBIX.
Which is the larger company: NBIX or AAPL?
Apple Inc (AAPL) is larger with a market cap of $3.83T compared to $13.21B for NBIX.
Should I buy NBIX or AAPL in 2026?
Both NBIX and AAPL have investment merit. NBIX trades at $153.88 while AAPL trades at $315.98. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between NBIX and AAPL stock?
Key differences: Market Cap ($13.21B vs $3.83T), P/E Ratio (31.6x vs 34.8x), Revenue Growth (27.8% vs 7.9%), Gross Margin (0.0% vs 46.9%).
Should I buy NBIX or AAPL in 2026?
The choice between NBIX and AAPL depends on your investment goals. NBIX shows higher revenue growth (27.8%). AAPL has better margins (46.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between NBIX and AAPL?
NBIX (Neurocrine Biosciences Inc) has a market cap of $13.21B, while AAPL (Apple Inc) has a market cap of $3.83T. AAPL is the larger company by market value.